Mission

Welcome to Mingowood Pharmacal. Our mission is to unlock the full potential of acidic cannabinoids through innovative formulation technology, delivering stabilized and efficacious solutions to diverse high-value markets. We are dedicated to maximizing the therapeutic benefits of acidic cannabinoids, including CBDA, THCA, and CBGA.

Our core innovation, the patented Intercalyx™ (Layered Double-Hydroxide) formulation technology, ensures the stability and enhances the potency of these crucial compounds.

Acidic cannabinoids hold immense promise for addressing unmet medical needs. However, their inherent instability presents a significant challenge. Our Intercalyx™ technology overcomes this, ensuring optimal delivery and protection for enhanced therapeutic outcomes.

By harnessing the power of acidic cannabinoids and leveraging our advanced formulation technology, we aim to redefine cannabinoid therapeutics. Join us in pioneering new frontiers in healthcare, one breakthrough at a time.

To learn more about the importance of acidic cannabinoids, click here. If you are interested in learning more about the science behind our formulation technology, click here.